Luminary Therapeutics

Minneapolis, United States

Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases.

$5.8M raised

Mar 2025

Grant

Biotechnology Health Care Life Science Oncology

Top Investors

Advanced Research Projects Agency for Health ScaleReady

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Luminary Therapeutics

How much funding has Luminary Therapeutics raised?

Luminary Therapeutics has raised $5.8M in total funding. The most recent round was Grant. The last funding was announced in March 2025.

Who are Luminary Therapeutics's investors?

Luminary Therapeutics's investors include Advanced Research Projects Agency for Health, ScaleReady.

Where is Luminary Therapeutics headquartered?

Luminary Therapeutics is headquartered in Minneapolis, United States.

What does Luminary Therapeutics do?

Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases.

What stage is Luminary Therapeutics at?

Luminary Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 11, 2025.

MLA

"Luminary Therapeutics — Funding & Investors." VCBacked, March 11, 2025, https://www.vcbacked.co/company/luminary-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Luminary Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/luminary-therapeutics

Wikipedia (cite web)

{{cite web |title=Luminary Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/luminary-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 11, 2025.